Overview 2018-05-15T15:58:53+00:00


Research Process Pre-clinical Phase 1 Phase 2 Phase 3
ALT-P1 Long-acting Human Growth Hormone
Domestic Phase II in Progress / Preparation of Phase II in Europe
ALT-Q2 Long-acting Factor Vlla
Process Development in Progress
ALT-P7 Breast/Gastric Cancer ADC
First-in human Domestic Phase I Clinical Trial in Progress
ALT-Q5 Ovarian Cancer ADC
Process Development in Progress
ALT-L9 Eylea Biosimilar
Preparation of Phase I Clinical Trial
ALT-L2 Herceptin Biosimilar
Preparation of Global Phase III Clinical Trial